Why is Jeevan Scientific Technology Ltd ?
1
Weak Long Term Fundamental Strength with a -25.88% CAGR growth in Operating Profits over the last 5 years
- The company has been able to generate a Return on Equity (avg) of 4.78% signifying low profitability per unit of shareholders funds
2
With a growth in Net Sales of 111.63%, the company declared Outstanding results in Mar 26
- The company has declared positive results for the last 2 consecutive quarters
- PAT(9M) At Rs 2.94 cr has Grown at 409.47%
- NET SALES(9M) At Rs 52.74 cr has Grown at 55.25%
- PBT LESS OI(Q) At Rs 2.27 cr has Grown at 184.07%
3
With ROCE of 3.8, it has a Attractive valuation with a 2 Enterprise value to Capital Employed
- The stock is trading at a discount compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of 92.58%, its profits have fallen by -30%
4
Promoter holding has decreased this quarter and now hold 30.25% of the company
5
Market Beating performance in long term as well as near term
- Along with generating 92.58% returns in the last 1 year, the stock has outperformed BSE500 in the last 3 years, 1 year and 3 months
How much should you hold?
- Overall Portfolio exposure to Jeevan Scienti. should be less than 10%
- Overall Portfolio exposure to Healthcare Services should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Healthcare Services)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Jeevan Scienti. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Jeevan Scienti.
92.58%
1.97
46.96%
Sensex
-7.92%
-0.61
13.09%
Quality key factors
Factor
Value
Sales Growth (5y)
5.15%
EBIT Growth (5y)
-25.88%
EBIT to Interest (avg)
2.04
Debt to EBITDA (avg)
3.60
Net Debt to Equity (avg)
0.16
Sales to Capital Employed (avg)
0.79
Tax Ratio
50.72%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
12.19%
ROE (avg)
4.78%
Valuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
33
Price to Book Value
2.13
EV to EBIT
51.65
EV to EBITDA
16.76
EV to Capital Employed
1.97
EV to Sales
2.68
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
3.81%
ROE (Latest)
-0.22%
Loading Valuation Snapshot...
Technical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
Bearish
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bearish
Mildly Bullish
Technical Movement
30What is working for the Company
PAT(9M)
At Rs 2.94 cr has Grown at 409.47%
NET SALES(9M)
At Rs 52.74 cr has Grown at 55.25%
PBT LESS OI(Q)
At Rs 2.27 cr has Grown at 184.07%
CASH AND CASH EQUIVALENTS(HY)
Highest at Rs 9.51 cr
0What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Loading Valuation Snapshot...
Here's what is working for Jeevan Scienti.
Net Sales - Quarterly
At Rs 21.29 cr has Grown at 111.63%
Year on Year (YoY)MOJO Watch
Near term sales trend is very positive
Net Sales (Rs Cr)
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 2.27 cr has Grown at 184.07%
Year on Year (YoY)MOJO Watch
Near term PBT trend is very positive
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
At Rs 1.61 cr has Grown at 223.8%
Year on Year (YoY)MOJO Watch
Near term PAT trend is very positive
PAT (Rs Cr)
Net Sales - Quarterly
Highest at Rs 21.29 cr
in the last five quartersMOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Profit After Tax (PAT) - Quarterly
Highest at Rs 1.61 cr.
in the last five quartersMOJO Watch
Near term PAT trend is positive
PAT (Rs Cr)
Cash and Cash Equivalents - Half Yearly
Highest at Rs 9.51 cr
in the last six half yearly periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents






